| Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual … SG Muthuri, S Venkatesan, PR Myles, J Leonardi-Bee, TSA Al Khuwaitir, ... The lancet Respiratory medicine 2 (5), 395-404, 2014 | 741 | 2014 |
| Impact of neuraminidase inhibitor treatment on outcomes of public health importance during the 2009-10 influenza A (H1N1) pandemic: a systematic review and meta-analysis in … SG Muthuri, PR Myles, S Venkatesan, J Leonardi-Bee, ... Journal of Infectious Diseases, 2012 | 238 | 2012 |
| Impact of outpatient neuraminidase inhibitor treatment in patients infected with influenza A (H1N1) pdm09 at high risk of hospitalization: an individual participant data … S Venkatesan, PR Myles, J Leonardi-Bee, SG Muthuri, M Al Masri, ... Clinical Infectious Diseases 64 (10), 1328-1334, 2017 | 92 | 2017 |
| Impact of neuraminidase inhibitors on influenza A (H1N1) pdm09‐related pneumonia: an individual participant data meta‐analysis SG Muthuri, S Venkatesan, PR Myles, J Leonardi‐Bee, WS Lim, ... Influenza and other respiratory viruses 10 (3), 192-204, 2016 | 81 | 2016 |
| Cohort study of preoperative blood pressure and risk of 30-day mortality after elective non-cardiac surgery S Venkatesan, PR Myles, HJ Manning, AM Mozid, C Andersson, ... BJA: British Journal of Anaesthesia 119 (1), 65-77, 2017 | 67 | 2017 |
| Neuraminidase inhibitors: who, when, where? JS Nguyen-Van-Tam, S Venkatesan, SG Muthuri, PR Myles Clinical Microbiology and Infection, 2014 | 60 | 2014 |
| Patient characteristics associated with COVID-19 positivity and fatality in Nigeria: retrospective cohort study KO Elimian, CL Ochu, B Ebhodaghe, P Myles, EE Crawford, E Igumbor, ... BMJ open 10 (12), e044079, 2020 | 59 | 2020 |
| Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM study RA Evans, S Dube, Y Lu, M Yates, S Arnetorp, E Barnes, S Bell, L Carty, ... The Lancet Regional Health–Europe 35, 2023 | 49 | 2023 |
| Factors determining intention to quit tobacco: exploring patient responses visiting public health facilities in India R Panda, S Venkatesan, D Persai, M Trivedi, MR Mathur Tobacco induced diseases 12, 1-10, 2014 | 40 | 2014 |
| Neuraminidase inhibitors and hospital length of stay: a meta-analysis of individual participant data to determine treatment effectiveness among patients hospitalized with … S Venkatesan, PR Myles, KJ Bolton, SG Muthuri, T Al Khuwaitir, ... The Journal of infectious diseases 221 (3), 356-366, 2020 | 35 | 2020 |
| Beta-blockers in noncardiac surgery: Did observational studies put us back on safe ground? ME Jørgensen, C Andersson, S Venkatesan, RD Sanders British Journal of Anaesthesia 121 (1), 16-25, 2018 | 27 | 2018 |
| Missed opportunities for brief intervention in tobacco control in primary care: patients’ perspectives from primary health care settings in India R Panda, D Persai, S Venkatesan BMC health services research 15, 1-9, 2015 | 23 | 2015 |
| Preoperative chronic beta-blocker prescription in elderly patients as a risk factor for postoperative mortality stratified by preoperative blood pressure: a cohort study S Venkatesan, ME Jørgensen, HJ Manning, C Andersson, AM Mozid, ... British Journal of Anaesthesia 123 (2), 118-125, 2019 | 19 | 2019 |
| Treatment patterns and outcomes for patients with malignant pleural mesothelioma in England in 2013–2017: A nationwide CAS registry analysis from the IO Optimise initiative P Baas, MJ Daumont, L Lacoin, JR Penrod, R Carroll, S Venkatesan, ... Lung Cancer 162, 185-193, 2021 | 18 | 2021 |
| Effects of five preoperative cardiovascular drugs on mortality after coronary artery bypass surgery: a retrospective analysis of an observational study of 16 192 patients S Venkatesan, GN Okoli, AM Mozid, TWH Pickworth, MPW Grocott, ... European Journal of Anaesthesiology| EJA 33 (1), 49-57, 2016 | 14 | 2016 |
| Statistical and methodological concerns about the beneficial effect of neuraminidase inhibitors on mortality. J Leonardi-Bee, S Venkatesan, SG Muthuri, JS Nguyen-Van-Tam, ... The Lancet Respiratory Medicine 2 (7), e10, 2014 | 14 | 2014 |
| Does receipt of 5As services have implications for patients’ satisfaction in India? D Persai, R Panda, S Venkatesan, M Arora, JS Ahluwalia BMC Family Practice 15, 1-7, 2014 | 12 | 2014 |
| A systematic review of the impact of neuraminidase inhibitor antiviral use on outcomes of public health importance during the 2009/10 (swine) influenza A/H1N1v pandemic P Myles, J Leonardi-Bee, J Van-Tam, S Muthuri, S Venkatesan PROSPERO, 2011 | 12 | 2011 |
| A novel framework for evaluating the impact of individual decision-making on public health outcomes and its potential application to study antiviral treatment collection during … S Venkatesan, JS Nguyen-Van-Tam, PO Siebers PLoS One 14 (10), e0223946, 2019 | 11 | 2019 |
| Physician and patient concordance of report of tobacco cessation intervention in primary care in India R Panda, D Persai, S Venkatesan, JS Ahluwalia BMC Public Health 15, 1-7, 2015 | 10 | 2015 |
Puja mylesAssociate Professor Health Protection and Epidemiology, University of Nottingham在 nottingham.ac.uk 的电子邮件经过验证
